Description
An agonist of the adenosine A2A receptor and an inhibitor of ENT1 (Kis = 4.39 and 3.47 µM, for the human receptor and guinea pig transporter, respectively); decreases adenosine uptake by 80% in PC12 cells at 61 µM and increases brain levels of adenosine in a transgenic mouse model of Huntington’s disease at 20 mg/kg; rescues motor performance and increases survival in a transgenic mouse model of Huntington’s disease at 0.11 mg/kg
Formal name: N-[2-(1H-indol-3-yl)ethyl]-adenosine
Synonyms: JMF 1907
Molecular weight: 410.4
CAS: 41552-95-8
Purity: ≥98%
Formulation: A solid